U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893588) titled 'Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts' on Feb. 03.

Brief Summary: A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)

Study Start Date: April 14

Study Type: OBSERVATIONAL

Condition: Cerebral Vasospasm Aneurysmal Subarachnoid Hemorrhage (aSAH)

Intervention: DEVICE: NEVA VS

cerebral artery dilation device

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vesalio

Disclaimer: Curated by HT Syndication....